LCZ696 (sacubitril/valsartan)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for LCZ696 (sacubitril/valsartan), covering 2015-08-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy [Phase 3]